Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

导管精准宣布，VIVO欧洲注册数据最新临床数据已在上周在心脏机器人导航学会议上发布；17（≈95%）名患者成功进行了消融手术；83%的患者未出现复发。

Benzinga · 11/04 08:42

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Cathter Precision宣布，来自VIVO欧盟注册机构的新临床数据已于上周在心脏学会机器人导航会议上公布；17名（约95％）名患者成功进行了消融手术；83％的患者在消融后的12个月内没有心律失常复发

Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company, today announced that new clinical data from the VIVO EU Registry was presented last week at the Society of Cardiac Robotic Navigation (SCRN) meeting in Lisbon, Portugal.

总部位于美国的创新医疗器械公司Catheter Precision, Inc.（纽约证券交易所代码：VTAK）今天宣布，来自VIVO欧盟注册机构的新临床数据已于上周在葡萄牙里斯本举行的心脏机器人导航学会（SCRN）会议上公布。

As previously announced, there were three presentations about VIVO during the SCRN meeting which took place October 28-29. The presentation by Professor Leonor Parreira shared the final data from Hospital da Luz. This center enrolled 27 subjects of which 18 proceeded with an ablation procedure with the following results:

正如先前宣布的那样，在10月28日至29日举行的SCRN会议期间，有三场关于VIVO的演讲。莱昂诺尔·帕雷拉教授的演讲分享了达卢兹医院的最终数据。该中心招收了27名受试者，其中18名接受了消融手术，结果如下：

100% accurate identification of the site of origin to the exact or neighboring cardiac segment

100% 准确识别确切或邻近心脏段的起源部位

17 (≈95%) patients had successful ablation procedures

17 (≥ 95%) 名患者成功进行了消融手术

83% of patients had no recurrence of the arrhythmia at 12 months post ablation

83% 的患者在消融后 12 个月内没有心律失常复发

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The...

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Catheter Precision Announces That New Clinical Data From The VIVO EU Registry Was Presented Last Week At The Society Of Cardiac Robotic Navigation Meeting; 17 (≈95%) Patients Had Successful Ablation Procedures; 83% Of Patients Had No Recurrence Of The Arrhythmia At 12 Months Post Ablation

Cathter Precision宣布，来自VIVO欧盟注册机构的新临床数据已于上周在心脏学会机器人导航会议上公布；17名（约95％）名患者成功进行了消融手术；83％的患者在消融后的12个月内没有心律失常复发

风险及免责提示

声明